Eli Lilly Cuts Zepbound Vial Prices

Eli Lilly lowered the cash prices of single-dose Zepbound vials on its LillyDirect platform, dropping the starting dose to $299 per month.

Transcript

00:00Eli Lilly lowered the cash prices of single-dose ZEP-bound vials on its Lilly Direct platform,

00:06dropping the starting dose to $2.99 a month and reducing all higher doses as competition

00:11with Novo Nordisk heats up. The move comes alongside broader federal efforts under the

00:16Trump White House to expand affordability and coverage of GLP-1 weight loss drugs,

00:21including upcoming Medicare access and discounted options via the new TrumpRx site.

00:27Lilly's cuts apply to vials already on the market, potentially speeding patient access

00:32ahead of anticipated discounts on multi-dose pens once they receive FDA approval.